Clinical Trial

FungiScope - A Global Emerging Fungal Infection Registry

Name: FungiScope - A Global Emerging Fungal Infection Registry — clinical trial record (NCT01731353)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FungiScope

Recruiting

View on ClinicalTrials.gov →

Summary

The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.

Protocol Amendment History 6 amendments

This ClinicalTrials.gov record has been amended 6 times since 2012-11-15; most recent amendment 2023-12-04.

Trial Details

NCT Number	NCT01731353
Lead Sponsor	University of Cologne Collaborators: Pfizer, Basilea Pharmaceutica, Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), F2G Biotech GmbH, Matinas Biopharma, Inc
Conditions	Invasive Fungal Disease
Enrollment	1,000 participants
Start Date	2003-03
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2023-12-05